​

Inspire Medical Systems (INSP) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

INSP Stock Forecast

Inspire Medical Systems (INSP) stock forecast, based on 22 Wall Street analysts, predicts a 12-month average price target of $242.33, with a high of $260.00 and a low of $215.00. This represents a 61.33% increase from the last price of $150.21.

$100 $140 $180 $220 $260 $300 High: $260 Avg: $242.33 Low: $215 Last Closed Price: $150.21

INSP Stock Rating

Inspire Medical Systems stock's rating consensus is Buy, based on 22 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (77.27%), 5 Hold (22.73%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 22 0 5 17 Strong Sell Sell Hold Buy Strong Buy

INSP Price Target Upside V Benchmarks

TypeNameUpside
StockInspire Medical Systems61.33%
SectorHealthcare Stocks 35.25%
IndustryMedical Device Stocks21.20%

Price Target Trends

1M3M12M
# Anlaysts1111
Avg Price Target$215.00$215.00$228.09
Last Closing Price$150.21$150.21$150.21
Upside/Downside43.13%43.13%51.85%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25485--17
Mar, 25485--17
Feb, 25485--17
Jan, 25485--17
Dec, 24485--17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 15, 2025Shagun SinghRBC Capital$215.00$146.2447.02%43.13%
Nov 05, 2024Adam MaederPiper Sandler$260.00$199.0030.65%73.09%
Nov 05, 2024David RescottRobert W. Baird$252.00$199.0026.63%67.77%
Oct 15, 2024David RescottRobert W. Baird$240.00$210.4614.04%59.78%
Jul 29, 2024Michael SarconeJefferies$230.00$129.7977.21%53.12%
Jul 16, 2024Richard NewitterTruist Financial$217.00$138.5856.59%44.46%
Jul 15, 2024Kallum TitchmarshMorgan Stanley$210.00$138.8951.20%39.80%
Jun 25, 2024Adam MaederPiper Sandler$255.00$139.4082.93%69.76%
Jun 24, 2024Jonathan BlockStifel Nicolaus$170.00$162.464.64%13.17%
Jun 11, 2024Paige MeyerCFRA$175.00$166.325.22%16.50%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 15, 2025RBC CapitalOutperformOutperformhold
Nov 20, 2024Bank of America SecuritiesNeutralBuyupgrade
Sep 30, 2024Truist FinancialMarket PerformMarket Performhold
Sep 10, 2024RBC CapitalMarket PerformMarket Performhold
Jul 29, 2024JefferiesBuyBuyhold
Jul 15, 2024Morgan StanleyOverweightOverweighthold
Jun 25, 2024Piper SandlerOverweightOverweighthold
Jun 24, 2024RBC CapitalBuyBuyhold
Jun 11, 2024CFRAHoldHoldhold
Jun 03, 2024RBC CapitalBuyBuyhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 $4 $5 $6 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.19$-1.54$-1.60$-0.72$1.80----
Avg Forecast$-2.40$-1.89$-2.29$-1.29$1.34$1.97$3.21$4.15$5.66
High Forecast$-2.31$-1.82$-2.26$-1.08$1.43$2.51$3.79$4.25$5.69
Low Forecast$-2.45$-1.93$-2.32$-1.62$1.28$1.68$2.86$3.98$5.62
Surprise %-8.75%-18.52%-30.13%-44.19%34.33%----

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$115.38M$233.39M$407.86M$624.80M$802.80M----
Avg Forecast$111.30M$229.61M$401.02M$619.50M$799.62M$949.63M$1.12B$1.31B$1.53B
High Forecast$112.86M$232.81M$405.36M$619.55M$802.83M$952.32M$1.12B$1.31B$1.53B
Low Forecast$108.06M$222.91M$396.31M$619.48M$795.90M$945.71M$1.12B$1.31B$1.52B
Surprise %3.66%1.65%1.70%0.86%0.40%----

Net Income Forecast

$-100M $-40M $20M $80M $140M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-57.20M$-42.04M$-44.88M$-21.15M$53.51M----
Avg Forecast$-64.27M$-51.71M$-59.56M$-21.15M$39.71M$59.68M$92.64M$116.87M$165.97M
High Forecast$-51.42M$-41.37M$-47.65M$-16.92M$42.03M$73.68M$111.15M$124.43M$166.77M
Low Forecast$-77.13M$-62.05M$-71.47M$-25.38M$37.39M$49.22M$83.92M$116.59M$164.54M
Surprise %-11.00%-18.69%-24.64%-34.76%----

INSP Forecast FAQ

Is Inspire Medical Systems stock a buy?

Inspire Medical Systems stock has a consensus rating of Buy, based on 22 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Inspire Medical Systems is a favorable investment for most analysts.

What is Inspire Medical Systems's price target?

Inspire Medical Systems's price target, set by 22 Wall Street analysts, averages $242.33 over the next 12 months. The price target range spans from $215 at the low end to $260 at the high end, suggesting a potential 61.33% change from the previous closing price of $150.21.

How does Inspire Medical Systems stock forecast compare to its benchmarks?

Inspire Medical Systems's stock forecast shows a 61.33% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical device stocks industry (21.20%).

What is the breakdown of analyst ratings for Inspire Medical Systems over the past three months?

  • April 2025: 23.53% Strong Buy, 47.06% Buy, 29.41% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 23.53% Strong Buy, 47.06% Buy, 29.41% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 23.53% Strong Buy, 47.06% Buy, 29.41% Hold, 0% Sell, 0% Strong Sell.

What is Inspire Medical Systems’s EPS forecast?

Inspire Medical Systems's average annual EPS forecast for its fiscal year ending in December 2025 is $1.97, marking a 9.44% increase from the reported $1.8 in 2024. Estimates for the following years are $3.21 in 2026, $4.15 in 2027, and $5.66 in 2028.

What is Inspire Medical Systems’s revenue forecast?

Inspire Medical Systems's average annual revenue forecast for its fiscal year ending in December 2025 is $949.63M, reflecting a 18.29% increase from the reported $802.8M in 2024. The forecast for 2026 is $1.12B, followed by $1.31B for 2027, and $1.53B for 2028.

What is Inspire Medical Systems’s net income forecast?

Inspire Medical Systems's net income forecast for the fiscal year ending in December 2025 stands at $59.68M, representing an 11.53% increase from the reported $53.51M in 2024. Projections indicate $92.64M in 2026, $116.87M in 2027, and $165.97M in 2028.